
Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
6 Tire Brands Reasonable for Seniors - 2
6 Web-based Lawful Administrations: Extensive Surveys and Elements - 3
Native Americans had dice and games of probability long before other cultures, study finds - 4
Most loved Fish Dish: What's Your Sea Pleasure? - 5
Former school bus aide pleads guilty to assaulting 3 autistic students in Colorado
19 Strange Motion pictures You Shouldn't Watch With Your Mum
Ministry: New German petrol price regulation takes effect on April 1
Consumer outlook on UK economy falls to two-year low
Golden Globes 2026 full nominations list: 'One Battle After Another' and 'The White Lotus' lead in film and television categories
21 Incredibly Entertaining Contemplations To Observe Consistently
From Modesty to Administration: Self-improvement in Interactive abilities
4 Famous Attractions at Disneyland
Smoking rate among US adults drops to record low as vape use rises, CDC report finds
Nations for Youngsters to Visit













